The Biology of Geller Syndrome: Why the Body Retains Salt
At a Glance
Geller syndrome is a rare genetic cause of high blood pressure in which a kidney salt receptor stays active, causing salt and water retention and low potassium. In the classic form, pregnancy hormones can make blood pressure rise sharply.
To understand Geller syndrome, it helps to think of your kidneys as a complex filtration system that uses “sensors” to decide how much salt and water to keep in your blood. The most important sensor for salt balance is the mineralocorticoid receptor (MR) [1][2].
In a typical body, this receptor acts like a gatekeeper. It stays “closed” or inactive until a hormone called aldosterone binds to it. When aldosterone arrives, the receptor turns “on,” telling the kidneys to pull salt (sodium) back into the bloodstream. This process naturally raises blood pressure to healthy levels when needed [3][4].
The Mutation: An Inappropriate “On” Signal
Geller syndrome is caused by a specific genetic change, most classically the S810L mutation in the NR3C2 gene [1]. This is known as a gain-of-function variant because it makes the receptor overactive.
Instead of waiting for a signal from aldosterone, the mutated receptor is “leaky”—it is more easily activated [5][1]. This causes the kidneys to continuously reabsorb salt and water, leading to early-onset high blood pressure. At the same time, this overactivity forces the kidneys to flush out too much potassium, resulting in hypokalemia (low blood potassium) [1][4].
The Progesterone Paradox
The most striking biological feature of the classic S810L variant of Geller syndrome is how it reacts to progesterone, a hormone that increases significantly during pregnancy.
- Normally: Progesterone is an antagonist to the mineralocorticoid receptor. This means it usually blocks the receptor, helping to keep blood pressure from getting too high during pregnancy [6][1].
- In Geller Syndrome: Because of the S810L mutation, the receptor’s shape is slightly different. Instead of blocking the receptor, progesterone fits into it perfectly and acts as a powerful agonist (a trigger) [7][8].
When progesterone levels rise during pregnancy, they activate these mutated receptors, driving blood pressure dangerously high and causing potassium to drop rapidly [1][9]. This effect typically reverses shortly after the baby is born and progesterone levels fall [1][10].
Distinguishing Geller Syndrome from Similar Conditions
Because Geller syndrome causes high blood pressure and low potassium, it can be confused with other disorders. Doctors use blood tests to look at renin and aldosterone levels to tell them apart.
| Condition | Renin Level | Aldosterone Level | Key Biological Difference |
|---|---|---|---|
| Geller Syndrome | Low (Suppressed) | Low (Suppressed) | Receptor is inappropriately active and can be triggered by progesterone [1]. |
| Primary Aldosteronism | Low | High | The body produces way too much aldosterone hormone [11]. |
| Liddle Syndrome | Low | Low | A different part of the kidney (the salt channel itself) is overactive [12]. |
| Apparent Mineralocorticoid Excess (AME) | Low | Low | The body can’t “deactivate” cortisol, so cortisol triggers the salt receptor instead [13]. |
A Note on Medications
The biology of the S810L mutation also changes how certain drugs work. For example, spironolactone is a common blood pressure medication that normally blocks the MR receptor. However, in people with the classic S810L mutation, spironolactone can actually activate the receptor, potentially making the condition worse [5]. Medication implications may depend on the exact variant you have, which is why an accurate genetic diagnosis and specialist interpretation are essential.
Common questions in this guide
What causes Geller syndrome?
Why can pregnancy make Geller syndrome worse?
What do low renin and low aldosterone mean in Geller syndrome?
Why might spironolactone be unsafe for some people with Geller syndrome?
How is Geller syndrome diagnosed?
What signs might suggest Geller syndrome rather than ordinary high blood pressure?
Get notified when new evidence is published on Hypertension due to gain-of-function mutations in the mineralocorticoid receptor.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (13)
- 1
A Case Report of Recurrent Hypokalemia During Pregnancies Associated With Nonaldosterone-Mediated Renal Potassium Loss.
Pintavorn P, Munie S
Canadian journal of kidney health and disease 2021; (8()):20543581211017424 doi:10.1177/20543581211017424.
PMID: 34104455 - 2
Critical role of the mineralocorticoid receptor in aldosterone-dependent and aldosterone-independent regulation of ENaC in the distal nephron.
Nesterov V, Bertog M, Canonica J, et al.
American journal of physiology. Renal physiology 2021; (321(3)):F257-F268 doi:10.1152/ajprenal.00139.2021.
PMID: 34251271 - 3
The mineralocorticoid receptor (MR) regulates ENaC but not NCC in mice with random MR deletion.
Czogalla J, Vohra T, Penton D, et al.
Pflugers Archiv : European journal of physiology 2016; (468(5)):849-58 doi:10.1007/s00424-016-1798-5.
PMID: 26898302 - 4
[Regulation of kidney on potassium balance and its clinical significance].
Xie QH, Hao CM
Sheng li xue bao : [Acta physiologica Sinica] 2023; (75(2)):216-230.
PMID: 37089096 - 5
Finerenone Impedes Aldosterone-dependent Nuclear Import of the Mineralocorticoid Receptor and Prevents Genomic Recruitment of Steroid Receptor Coactivator-1.
Amazit L, Le Billan F, Kolkhof P, et al.
The Journal of biological chemistry 2015; (290(36)):21876-89 doi:10.1074/jbc.M115.657957.
PMID: 26203193 - 6
Progesterone: An enigmatic ligand for the mineralocorticoid receptor.
Baker ME, Katsu Y
Biochemical pharmacology 2020; (177()):113976 doi:10.1016/j.bcp.2020.113976.
PMID: 32305433 - 7
Structural determinants of activation of the mineralocorticoid receptor: an evolutionary perspective.
Fuller PJ, Yao YZ, Yang J, Young MJ
Journal of human hypertension 2021; (35(2)):110-116 doi:10.1038/s41371-020-0360-2.
PMID: 32467588 - 8
Clinical and Molecular Perspectives of Monogenic Hypertension.
Levanovich PE, Diaczok A, Rossi NF
Current hypertension reviews 2020; (16(2)):91-107 doi:10.2174/1573402115666190409115330.
PMID: 30963979 - 9
First European case of Geller syndrome complicated with hypokalemic nephropathy: A case report and literature review.
Gavriilidis E, Antoniadou C, Dimopoulou G, et al.
Metabolism open 2026; (29()):100429 doi:10.1016/j.metop.2025.100429.
PMID: 41487602 - 10
Refractory Hypokalemia of Pregnancy: A Rare Case of Non-Aldosterone Mediated Hypokalemia.
Valiveti D, Lahey O, Nooruddin K, Addison B
Cureus 2025; (17(2)):e79242 doi:10.7759/cureus.79242.
PMID: 40115718 - 11
The Expanding Spectrum of Primary Aldosteronism: Implications for Diagnosis, Pathogenesis, and Treatment.
Vaidya A, Mulatero P, Baudrand R, Adler GK
Endocrine reviews 2018; (39(6)):1057-1088 doi:10.1210/er.2018-00139.
PMID: 30124805 - 12
Monogenic Kidney Disorders as Hidden Drivers of Electrolyte Imbalance and Hypertension.
Ahn YH
Electrolyte & blood pressure : E & BP 2026; (24(3)):147-157 doi:10.5049/EBP.2026.24.e15.
PMID: 42812492 - 13
Apparent mineralocorticoid excess mimicking Bartter syndrome in infancy.
Hatipoğlu S, Yıldırım E, Şalbaş ÖY, et al.
Journal of pediatric endocrinology & metabolism : JPEM 2026; doi:10.1515/jpem-2026-0333.
PMID: 42912472
This page is for informational purposes only and does not replace medical advice. An endocrinologist, nephrologist, or genetics specialist should interpret your hormone tests and NR3C2 variant and guide medication decisions.